Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

~26 mi. (La Roche-sur-Yon, France, +158 more cities)

CHD Vendee ( Site 0807)

Non-Small Cell Lung Carcinoma

olaparib, +4 more drugs

chemotherapy, +3 more types

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

~26 mi. (La Roche-sur-Yon, France, +126 more cities)

CHD Vendee ( Site 0227)

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

FOLFOX regimen, +3 more drugs

chemotherapy, +2 more types

Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

~26 mi. (La Roche-sur-Yon, France, +115 more cities)

CHD Vendee ( Site 0604)

ATM Loss, +27 more biomarkers

Breast Carcinoma, +2 more conditions

olaparib, +1 more drug

immunotherapy, +1 more type

Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With CLL or SLL

~26 mi. (La Roche-sur-Yon, France, +71 more cities)

CHD Vendee

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

pirtobrutinib

targeted therapy

An Open-Label, Phase 2 Trial of Nanatinostat in Combination With Valganciclovir in Patients With Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas

~26 mi. (La Roche-sur-Yon, France, +48 more cities)

Centre Hospitalier Départemental Vendée

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, +4 more conditions

nanatinostat, +1 more drug

Other, +1 more type

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

~75 mi. (Nantes, France, +176 more cities)

Hopital prive du Confluent ( Site 2061)

Endometrial Carcinoma, +1 more condition

chemotherapy, +2 more drugs

chemotherapy, +2 more types

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

~75 mi. (Nantes, France, +163 more cities)

CHU Hotel Dieu Nantes ( Site 0458)

Bladder Urothelial Carcinoma

cystectomy, +2 more drugs

chemotherapy, +3 more types

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)

~75 mi. (Nantes, France, +131 more cities)

CHU Hotel Dieu Nantes ( Site 1101)

HER2 Negative

Adenocarcinoma of the Gastroesophageal Junction, +2 more conditions

CAPOX regimen, +3 more drugs

chemotherapy, +2 more types

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

~75 mi. (Nantes, France, +201 more cities)

CHU de Nantes, Hotel Dieu -HME /ID# 222074

Myelodysplastic Syndromes

azacitidine, +1 more drug

chemotherapy

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)

~75 mi. (Nantes, France, +127 more cities)

CHU de Nantes, Hotel Dieu -HME /ID# 214060

Acute Myeloid Leukemia

azacitidine, +2 more drugs

chemotherapy

A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy

~75 mi. (Nantes, France, +197 more cities)

CHU de Nantes, Hotel Dieu -HME /ID# 217367

BCR-ABL1 Fusion, +47 more biomarkers

Acute Myeloid Leukemia

azacitidine, +1 more drug

chemotherapy

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

~75 mi. (Nantes, France, +96 more cities)

Centre Hospitalier Universitaire Nantes-Hotel Dieu

Diffuse Large B-Cell Lymphoma, +1 more condition

brentuximab vedotin, +2 more drugs

chemotherapy, +1 more type